These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 22971960)

  • 1. Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII.
    Rowan DJ; Tomatsu S; Grubb JH; Montaño AM; Sly WS
    J Inherit Metab Dis; 2013 Mar; 36(2):235-46. PubMed ID: 22971960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
    Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.
    Kubaski F; Suzuki Y; Orii K; Giugliani R; Church HJ; Mason RW; Dũng VC; Ngoc CT; Yamaguchi S; Kobayashi H; Girisha KM; Fukao T; Orii T; Tomatsu S
    Mol Genet Metab; 2017 Mar; 120(3):247-254. PubMed ID: 28065440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening and diagnosis of mucopolysaccharidoses.
    Tomatsu S; Fujii T; Fukushi M; Oguma T; Shimada T; Maeda M; Kida K; Shibata Y; Futatsumori H; Montaño AM; Mason RW; Yamaguchi S; Suzuki Y; Orii T
    Mol Genet Metab; 2013; 110(1-2):42-53. PubMed ID: 23860310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels.
    Dũng VC; Tomatsu S; Montaño AM; Gottesman G; Bober MB; Mackenzie W; Maeda M; Mitchell GA; Suzuki Y; Orii T
    Mol Genet Metab; 2013; 110(1-2):129-38. PubMed ID: 23876334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratan sulphate levels in mucopolysaccharidoses and mucolipidoses.
    Tomatsu S; Okamura K; Maeda H; Taketani T; Castrillon SV; Gutierrez MA; Nishioka T; Fachel AA; Orii KO; Grubb JH; Cooper A; Thornley M; Wraith E; Barrera LA; Laybauer LS; Giugliani R; Schwartz IV; Frenking GS; Beck M; Kircher SG; Paschke E; Yamaguchi S; Ullrich K; Haskins M; Isogai K; Suzuki Y; Orii T; Kondo N; Creer M; Okuyama T; Tanaka A; Noguchi A
    J Inherit Metab Dis; 2005; 28(2):187-202. PubMed ID: 15877208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model.
    Sawamoto K; Tomatsu S
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.
    Peracha H; Sawamoto K; Averill L; Kecskemethy H; Theroux M; Thacker M; Nagao K; Pizarro C; Mackenzie W; Kobayashi H; Yamaguchi S; Suzuki Y; Orii K; Orii T; Fukao T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):18-37. PubMed ID: 29779902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry.
    Kubaski F; Mason RW; Nakatomi A; Shintaku H; Xie L; van Vlies NN; Church H; Giugliani R; Kobayashi H; Yamaguchi S; Suzuki Y; Orii T; Fukao T; Montaño AM; Tomatsu S
    J Inherit Metab Dis; 2017 Jan; 40(1):151-158. PubMed ID: 27718145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone Growth Induction in Mucopolysaccharidosis IVA Mouse.
    Rintz E; Herreño-Pachón AM; Celik B; Nidhi F; Khan S; Benincore-Flórez E; Tomatsu S
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosaminoglycan levels and structure in a mucopolysaccharidosis IIIA mice and the effect of a highly secreted sulfamidase engineered to cross the blood-brain barrier.
    Maccari F; Sorrentino NC; Mantovani V; Galeotti F; Fraldi A; Volpi N
    Metab Brain Dis; 2017 Feb; 32(1):203-210. PubMed ID: 27585464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA.
    Tomatsu S; Okamura K; Taketani T; Orii KO; Nishioka T; Gutierrez MA; Velez-Castrillon S; Fachel AA; Grubb JH; Cooper A; Thornley M; Wraith E; Barrera LA; Giugliani R; Schwartz IV; Frenking GS; Beck M; Kircher SG; Paschke E; Yamaguchi S; Ullrich K; Isogai K; Suzuki Y; Orii T; Kondo N; Creer M; Noguchi A
    Pediatr Res; 2004 Apr; 55(4):592-7. PubMed ID: 14711889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-dimensional NMR spectroscopy of urinary glycosaminoglycans from patients with different mucopolysaccharidoses.
    Hochuli M; Wüthrich K; Steinmann B
    NMR Biomed; 2003 Jun; 16(4):224-36. PubMed ID: 14558120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice.
    Langford-Smith K; Arasaradnam M; Wraith JE; Wynn R; Bigger BW
    Mol Genet Metab; 2010 Mar; 99(3):269-74. PubMed ID: 19926322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucopolysaccharidosis IVA and glycosaminoglycans.
    Khan S; Alméciga-Díaz CJ; Sawamoto K; Mackenzie WG; Theroux MC; Pizarro C; Mason RW; Orii T; Tomatsu S
    Mol Genet Metab; 2017; 120(1-2):78-95. PubMed ID: 27979613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chondroitin 6-Sulfate as a Novel Biomarker for Mucopolysaccharidosis IVA and VII.
    Shimada T; Tomatsu S; Yasuda E; Mason RW; Mackenzie WG; Shibata Y; Kubaski F; Giugliani R; Yamaguchi S; Suzuki Y; Orii K; Orii T
    JIMD Rep; 2014; 16():15-24. PubMed ID: 24850234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry.
    Tomatsu S; Montaño AM; Oguma T; Dung VC; Oikawa H; de Carvalho TG; Gutiérrez ML; Yamaguchi S; Suzuki Y; Fukushi M; Kida K; Kubota M; Barrera L; Orii T
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S35-42. PubMed ID: 20107903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationships between urinary glycosaminoglycan levels and phenotypes of mucopolysaccharidoses.
    Lin HY; Lee CL; Lo YT; Wang TJ; Huang SF; Chen TL; Wang YS; Niu DM; Chuang CK; Lin SP
    Mol Genet Genomic Med; 2018 Nov; 6(6):982-992. PubMed ID: 30296009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel heparan sulfate assay by using automated high-throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses.
    Shimada T; Kelly J; LaMarr WA; van Vlies N; Yasuda E; Mason RW; Mackenzie W; Kubaski F; Giugliani R; Chinen Y; Yamaguchi S; Suzuki Y; Orii KE; Fukao T; Orii T; Tomatsu S
    Mol Genet Metab; 2014; 113(1-2):92-9. PubMed ID: 25092413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed hypertrophic differentiation of epiphyseal chondrocytes contributes to failed secondary ossification in mucopolysaccharidosis VII dogs.
    Peck SH; O'Donnell PJ; Kang JL; Malhotra NR; Dodge GR; Pacifici M; Shore EM; Haskins ME; Smith LJ
    Mol Genet Metab; 2015 Nov; 116(3):195-203. PubMed ID: 26422116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.